Inglis, L. (2024) ECG recordings for patients entered into the RelieHF study. [Data Collection]

Collection description

The RelieHF study was looking at heart failure patients and using the study drug Patiromer, a potassium removing agent. The aim was to trial the potential for increasing dosages to improve worsening congestion, well-being, morbidity and mortality in patients with heart failure and hyperkalaemia, with a view to comparison with standard care.

College / School:	College of Medical Veterinary and Life Sciences > School of Cardiovascular and Metabolic Health > Cardiovascular Science
Date Deposited:	27 Jun 2024 14:20
URI:	https://researchdata.gla.ac.uk/id/eprint/1667
Additional details Additional details Collection period: From To 26 August 2020 1 May 2023 Date: 26 June 2024 Additional information: Funded by VIFOR Pharma Management AG, Flughofstrasse 61, Postfach, CH-8152 Glattbrugg, Switzerland, Tel: +41 58 851 80 00 Resource language: English Data Publisher: University of Glasgow Copyright holders: University of Glasgow Last Modified: 12 Sep 2025 08:55

Available Files

Documentation

OBSOLETE-202001 ... Protocol_v4.pdf OBSOLETE-202001 ... Protocol_v4.pdf OBSOLETE-202001 ... Protocol_v4.pdf Visible to: Repository staff only File size: 1MB License: Not Suitable for Sharing

OBSOLETE-202002 ... Version.1.0.doc OBSOLETE-202002 ... Version.1.0.doc OBSOLETE-202002 ... Version.1.0.doc Visible to: Repository staff only File size: 3MB License: Not Suitable for Sharing

QPC19_RelieHF_Study.pdf QPC19_RelieHF_Study.pdf QPC19_RelieHF_Study.pdf Visible to: Repository staff only File size: 1MB License: Not Suitable for Sharing

Repository Staff Only: Update this record